Arena stock topped $25 in after-hours trading immediately following the announcement, after closing with a 4.5% decline …
Shares of Arena Pharmaceuticals (ARNA) opened at 20.73 on Thursday. The stock’s market capitalization is $659.19 …
Cantor Fitzgerald analyst William Tanner initiates coverage on Arena Pharma (NASDAQ: ARNA) with a Overweight …
We believe it reasonable that some investors may have harbored ambivalence towards ARNA stock given the track …
(NASDAQ:ARNA). Manufacturers Life Insur Co The accumulated 176,930 shares or 0% of the stock. The Barrick Gold Corporation (NYSE:ABX) Stock Rating Upgraded by Berenberg Bank Berenberg Bank now has $16.40 target price on …
Now Let me show you how we posted a buy call on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) when the stock
Among 6 analysts covering Arena Pharmaceuticals (NASDAQ:ARNA), 5 have Buy rating, 0 Sell and 1 Hold. Cantor Fitzgerald maintained the stock with "Buy" rating in Thursday, June 29 report. They now have a $37.00 target price on …
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)’s stock is scheduled to reverse split before the market opens on Monday, June 19th. The 1-10 reverse split was announced on Wednesday, June 14th. The number of shares owned by …
The stock has an average rating of "Buy" and an average price target of $36.00. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has declined 11.92% since July 20, 2016 and is downtrending. The firm has a 50-day moving average …
Among 6 analysts covering Arena Pharmaceuticals (NASDAQ:ARNA), 5 have Buy rating, 0 Sell and 1 Hold. Four research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Arena …